HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahiro Asaka Selected Research

Masahiro Asaka Research Topics

Disease

46Neoplasms (Cancer)
12/2021 - 08/2002
29Infections
06/2022 - 01/2002
22Stomach Neoplasms (Stomach Cancer)
10/2020 - 09/2003
15Colorectal Neoplasms (Colorectal Cancer)
04/2014 - 12/2004
10Ulcer
06/2022 - 01/2003
10Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2010 - 07/2003
10Graft vs Host Disease (Graft-Versus-Host Disease)
06/2009 - 03/2004
9Anorexia
09/2017 - 06/2008
9Colitis
01/2012 - 07/2002
8Peptic Ulcer (Peptic Ulcers)
06/2022 - 01/2003
8Inflammation (Inflammations)
10/2020 - 02/2005
8Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 02/2003
8Hypoxia (Hypoxemia)
01/2016 - 02/2003
8Carcinogenesis
02/2014 - 11/2003
8Gastroesophageal Reflux (GERD)
07/2012 - 04/2006
8Carcinoma (Carcinomatosis)
05/2012 - 01/2002
8Leukemia
03/2010 - 02/2003
7Lymphoma (Lymphomas)
05/2012 - 06/2004
7Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
07/2011 - 11/2003
7Neutropenia
07/2010 - 05/2004
6Neoplasm Metastasis (Metastasis)
01/2016 - 06/2004
6Hepatocellular Carcinoma (Hepatoma)
02/2014 - 03/2003
5Colonic Neoplasms (Colon Cancer)
12/2021 - 04/2008
5Wounds and Injuries (Trauma)
09/2017 - 10/2007
5Rheumatoid Arthritis
05/2012 - 01/2005
5Disease Progression
03/2011 - 09/2004
5Hematologic Neoplasms (Hematological Malignancy)
04/2010 - 02/2003
5Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2010 - 04/2005
4Pathologic Constriction (Stenosis)
09/2017 - 07/2011
4Dyspepsia (Indigestion)
09/2017 - 10/2010
4Multiple Myeloma
11/2008 - 12/2004
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008 - 05/2004
3Gastritis
10/2017 - 01/2002
3Vomiting
09/2017 - 06/2008
3Nausea
09/2017 - 06/2006
3Duodenal Ulcer (Curling's Ulcer)
01/2016 - 02/2010
3Thrombosis (Thrombus)
07/2011 - 10/2008
3Hemorrhage
04/2011 - 10/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2011 - 07/2003
3Stomach Ulcer (Gastric Ulcer)
11/2010 - 01/2006
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2010 - 04/2004
3Aplastic Anemia (Anemia, Hypoplastic)
05/2009 - 07/2002
3Laryngopharyngeal Reflux
08/2008 - 04/2006
3Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
07/2008 - 09/2004
3Pathologic Complete Response
05/2008 - 07/2003
3Adenocarcinoma
02/2007 - 01/2002

Drug/Important Bio-Agent (IBA)

12Pharmaceutical PreparationsIBA
05/2012 - 05/2005
11Proteins (Proteins, Gene)FDA Link
03/2017 - 11/2003
8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
06/2022 - 01/2005
8Rituximab (Mabthera)FDA Link
05/2012 - 03/2004
8Irinotecan (Camptosar)FDA LinkGeneric
08/2011 - 02/2005
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2011 - 10/2007
7liu-jun-zi-tangIBA
09/2017 - 06/2008
7Cisplatin (Platino)FDA LinkGeneric
09/2017 - 04/2007
7Macrophage Migration-Inhibitory FactorsIBA
04/2011 - 07/2002
6DNA (Deoxyribonucleic Acid)IBA
04/2013 - 02/2004
6Dextran SulfateIBA
01/2012 - 07/2002
5GhrelinIBA
01/2013 - 01/2010
5InterferonsIBA
11/2012 - 12/2004
5Messenger RNA (mRNA)IBA
07/2012 - 07/2002
5Fluorouracil (Carac)FDA LinkGeneric
08/2011 - 06/2007
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
02/2008 - 10/2004
4RNA (Ribonucleic Acid)IBA
12/2021 - 08/2003
4Lansoprazole (Prevacid)FDA LinkGeneric
01/2016 - 01/2003
4Clarithromycin (Biaxin)FDA LinkGeneric
01/2016 - 02/2002
4IodineIBA
01/2015 - 01/2006
4Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2014 - 09/2005
4Biological ProductsIBA
02/2014 - 08/2003
4Pepsinogen A (Pepsinogen)IBA
02/2013 - 12/2010
4CytokinesIBA
01/2011 - 07/2002
4Immunoglobulins (Immunoglobulin)IBA
10/2010 - 11/2005
4AcidsIBA
01/2009 - 04/2006
4SolutionsIBA
04/2008 - 09/2005
3Transcription Factors (Transcription Factor)IBA
01/2016 - 08/2003
3Peptides (Polypeptides)IBA
01/2016 - 02/2011
3Amoxicillin (Wymox)FDA LinkGeneric
01/2016 - 01/2003
3Serotonin (5 Hydroxytryptamine)IBA
01/2013 - 01/2011
3CarcinogensIBA
10/2012 - 01/2002
3Leucovorin (Folinic Acid)FDA Link
08/2011 - 06/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2009 - 09/2005
3Matrix Metalloproteinases (MMPs)IBA
11/2009 - 08/2005
3Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2009 - 09/2004
3Anti-Bacterial Agents (Antibiotics)IBA
05/2009 - 01/2007
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2008 - 07/2002
3Glucose (Dextrose)FDA LinkGeneric
09/2007 - 04/2003
3Therapeutic UsesIBA
07/2007 - 09/2005
3geranylgeranylacetone (teprenone)IBA
03/2006 - 09/2005
3Imatinib Mesylate (Gleevec)FDA Link
01/2006 - 10/2004

Therapy/Procedure

56Therapeutics
06/2022 - 02/2002
26Drug Therapy (Chemotherapy)
09/2017 - 07/2003
11Hematopoietic Stem Cell Transplantation
03/2011 - 02/2005
7Stem Cell Transplantation
03/2010 - 03/2004
6Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2008 - 07/2002
5Secondary Prevention
03/2013 - 10/2008
5Aftercare (After-Treatment)
07/2011 - 01/2003
5Transplantation
03/2011 - 09/2004
4Immunotherapy
01/2016 - 01/2005
4Kampo Medicine (Kampo)
07/2012 - 10/2010
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2008 - 07/2003
3Oral Administration
09/2017 - 09/2005